0001209191-19-031039.txt : 20190517
0001209191-19-031039.hdr.sgml : 20190517
20190517171756
ACCESSION NUMBER: 0001209191-19-031039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190516
FILED AS OF DATE: 20190517
DATE AS OF CHANGE: 20190517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBINO RICHARD J
CENTRAL INDEX KEY: 0001252014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 19836816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-16
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001252014
RUBINO RICHARD J
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
0
1
0
0
Chief Financial Officer
Common Stock
2019-05-16
4
A
0
13559
0.00
A
336728
D
Common Stock
2019-05-16
4
F
0
2322
40.54
D
334406
D
The reported transaction includes (i) 6,779 shares of common stock that vested on May 16, 2019 and (ii) 6,780 shares of common stock that will vest on May 16, 2020, subject to the reporting person's continued employment with the issuer through such date, pursuant to, in the case of each of clauses (i) and (ii), the issuer's compensation committee having determined that the requisite performance condition (the approval and launch of Rocklatan prior to September 30, 2019) has been achieved.
Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of performance-based restricted Common Stock.
/s/ John LaRocca, Attorney-in-Fact for Richard J. Rubino
2019-05-17